Karuna Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Karuna Therapeutics has a total shareholder equity of $1.3B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.3B and $82.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$1.26b |
Equity | US$1.25b |
Total liabilities | US$81.97m |
Total assets | US$1.34b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: KRTX *'s short term assets ($1.3B) exceed its short term liabilities ($68.1M).
Long Term Liabilities: KRTX *'s short term assets ($1.3B) exceed its long term liabilities ($13.8M).
Debt to Equity History and Analysis
Debt Level: KRTX * is debt free.
Reducing Debt: KRTX * has no debt compared to 5 years ago when its debt to equity ratio was 20.9%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KRTX * has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if KRTX * has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.